OTCMKTS:YECO EV Biologics (YECO) Stock Price, News & Analysis → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free YECO Stock Alerts $0.60 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.60▼$0.6050-Day Range$0.56▼$0.9952-Week Range$0.56▼$1.95VolumeN/AAverage Volume47 shsMarket Capitalization$6.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get EV Biologics alerts: Email Address Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. About EV Biologics Stock (OTCMKTS:YECO)EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.Read More YECO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YECO Stock News HeadlinesMarch 22, 2024 | morningstar.comNurExone Biologic Inc NRXBFFebruary 21, 2024 | usatoday.comBest EV stocks in February 2024April 25, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...January 24, 2024 | finance.yahoo.comSoft Tissue Biologics Product Pipeline Report 2023: Reveals Key Development Stages, Industry Trends, Regions, and CompaniesJanuary 24, 2024 | finance.yahoo.comFill Finish Manufacturing Market Forecast Report - A US$ 17.165 Billion Market by 2030, Amplified by Rising Demand for Prefilled SyringesDecember 15, 2023 | uk.investing.comY Biologics Inc (338840)October 17, 2023 | reuters.comChinese EV startup WM Motor files for pre-restructuringOctober 4, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Funding and SalesApril 25, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...October 2, 2023 | finance.yahoo.comEV Biologics Updates on Funding and SalesAugust 16, 2023 | finance.yahoo.comEV Biologics Completes Production of Cutting-Edge MSC Exosome-Based TherapeuticAugust 7, 2023 | finance.yahoo.comEV Biologics Appoints Senior Investment Banker as Corporate Finance DirectorAugust 3, 2023 | money.usnews.comHow the New EV Tax Credit Will Affect Your Auto LoanAugust 2, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Hires Senior Chief Financial OfficerAugust 2, 2023 | finance.yahoo.comEV Biologics Hires Senior Chief Financial OfficerJuly 30, 2023 | news.yahoo.comToyota is planning a new EV with a 900-mile range and 10-minute charging time: ‘The holy grail of battery vehicles’July 16, 2023 | usatoday.comAre you a gas guzzler? The government might try to persuade you to switch to an EVJune 21, 2023 | usatoday.comHow reliable are public EV charging stations? Report shows many EV drivers have issuesMay 27, 2023 | finance.yahoo.comEV Biologics, Inc. (YECO)May 17, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 15, 2023 | finance.yahoo.comEV Biologics Signs Exclusive Distribution Agreement for South AmericaMay 11, 2023 | benzinga.comBest EV Penny StocksApril 30, 2023 | washingtonpost.comGM to scrap Chevy Bolt, its most popular and least expensive EVMarch 19, 2023 | a.msn.comTesco EV charging network reaches 600 UK stores – and rapid chargers go liveFebruary 21, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Generates Mesenchymal Stem Cell LinesFebruary 21, 2023 | finance.yahoo.comEV Biologics Generates Mesenchymal Stem Cell LinesJanuary 3, 2023 | finanznachrichten.deEV Biologics Corporation: EV Biologics Updates on Excyte Subsidiary FundingSee More Headlines Receive YECO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConstruction Industry Concrete, gypsum, & plaster products Sub-IndustryN/A Current SymbolOTCMKTS:YECO CUSIPN/A CIK1607741 Webwww.evbiologics.com Phone(518) 638-8192FaxN/AEmployees284Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,230,000Free Float6,006,000Market Cap$6.16 million OptionableNot Optionable Beta-0.50 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Daniel S. McKinney (Age 62)Founder, Chairman & CEO Mr. Monte FisherChief Financial OfficerMr. William BossungCorporate Finance Director & Corporate SecretaryKey CompetitorsEnergy FocusNASDAQ:EFOICEA IndustriesNASDAQ:CEADENGlobalNASDAQ:ENGIntelligent Living Application GroupNASDAQ:ILAGWANG & LEE GROUPNASDAQ:WLGSView All Competitors YECO Stock Analysis - Frequently Asked Questions How have YECO shares performed in 2024? EV Biologics' stock was trading at $1.00 at the beginning of the year. Since then, YECO shares have decreased by 39.8% and is now trading at $0.6021. View the best growth stocks for 2024 here. Are investors shorting EV Biologics? EV Biologics saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a decline of 75.0% from the February 29th total of 400 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is presently 0.3 days. View EV Biologics' Short Interest. How do I buy shares of EV Biologics? Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:YECO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EV Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
